(S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE increases expression ISO RGD:620215 6480464 Topotecan results in increased expression of HIGD1A mRNA CTD PMID:25729387 (S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE multiple interactions ISO RGD:620215 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of HIGD1A mRNA CTD PMID:25729387 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of HIGD1A mRNA CTD PMID:17942748 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of HIGD1A mRNA CTD PMID:17555576 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of HIGD1A mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of HIGD1A mRNA CTD PMID:17942748 2,4-diaminotoluene increases expression EXP 6480464 2, 4-diaminotoluene results in increased expression of HIGD1A mRNA CTD PMID:20713471 2,4-dinitrotoluene affects expression ISO RGD:620215 6480464 2, 4-dinitrotoluene affects the expression of HIGD1A mRNA CTD PMID:21346803 2-hydroxypropanoic acid decreases expression ISO RGD:1603666 6480464 Lactic Acid results in decreased expression of HIGD1A mRNA CTD PMID:30851411 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:620215 6480464 3 more ... CTD PMID:23196670 3,3',5-triiodo-L-thyronine increases expression ISO RGD:620215 6480464 Triiodothyronine results in increased expression of HIGD1A mRNA CTD PMID:15953391 3H-1,2-dithiole-3-thione decreases expression ISO RGD:620215 6480464 1, 2-dithiol-3-thione results in decreased expression of HIGD1A mRNA CTD PMID:19162173 4-hydroxyphenyl retinamide decreases expression EXP 6480464 Fenretinide results in decreased expression of HIGD1A mRNA CTD PMID:28973697 aflatoxin B1 decreases expression ISO RGD:1603666 6480464 Aflatoxin B1 results in decreased expression of HIGD1A mRNA CTD PMID:22100608 aflatoxin B1 decreases methylation ISO RGD:1603666 6480464 Aflatoxin B1 results in decreased methylation of HIGD1A intron CTD PMID:30157460 ammonium chloride affects expression ISO RGD:620215 6480464 Ammonium Chloride affects the expression of HIGD1A mRNA CTD PMID:16483693 Aroclor 1254 decreases expression EXP 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of HIGD1A mRNA CTD PMID:23650126 arsane affects methylation ISO RGD:1603666 6480464 Arsenic affects the methylation of HIGD1A gene CTD PMID:25304211 arsenic atom affects methylation ISO RGD:1603666 6480464 Arsenic affects the methylation of HIGD1A gene CTD PMID:25304211 arsenic(3+) affects methylation ISO RGD:1603666 6480464 Arsenic affects the methylation of HIGD1A gene CTD PMID:25304211 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of HIGD1A mRNA CTD PMID:22228805 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1603666 6480464 Diethylhexyl Phthalate results in increased expression of HIGD1A mRNA CTD PMID:31163220 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of HIGD1A mRNA CTD PMID:26063408 bisphenol A decreases expression ISO RGD:1603666 6480464 bisphenol A results in decreased expression of HIGD1A mRNA CTD PMID:29275510 bisphenol A increases methylation ISO RGD:620215 6480464 bisphenol A results in increased methylation of HIGD1A gene CTD PMID:28505145 bisphenol A increases expression ISO RGD:620215 6480464 bisphenol A results in increased expression of HIGD1A mRNA CTD PMID:25181051 butanal decreases expression ISO RGD:1603666 6480464 butyraldehyde results in decreased expression of HIGD1A mRNA CTD PMID:26079696 carbon nanotube affects expression EXP 6480464 Nanotubes, Carbon affects the expression of HIGD1A mRNA CTD PMID:25620056 carbon nanotube decreases expression EXP 6480464 Nanotubes, Carbon analog results in decreased expression of HIGD1A mRNA CTD PMID:25620056 chloropicrin increases expression ISO RGD:1603666 6480464 chloropicrin results in increased expression of HIGD1A mRNA CTD PMID:26352163 clozapine increases expression EXP 6480464 Clozapine results in increased expression of HIGD1A mRNA CTD PMID:14647396 cobalt dichloride increases expression ISO RGD:620215 6480464 cobaltous chloride results in increased expression of HIGD1A mRNA CTD PMID:24386269 cocaine increases expression ISO RGD:620215 6480464 Cocaine results in increased expression of HIGD1A protein CTD PMID:25100957 cocaine affects expression ISO RGD:620215 6480464 Cocaine affects the expression of HIGD1A mRNA CTD PMID:20187946 copper atom multiple interactions ISO RGD:1603666 6480464 [NSC 689534 binds to Copper] which results in decreased expression of HIGD1A mRNA CTD PMID:20971185 copper(0) multiple interactions ISO RGD:1603666 6480464 [NSC 689534 binds to Copper] which results in decreased expression of HIGD1A mRNA CTD PMID:20971185 copper(2+) multiple interactions ISO RGD:1603666 6480464 [NSC 689534 binds to Copper] which results in decreased expression of HIGD1A mRNA CTD PMID:20971185 copper(II) sulfate decreases expression ISO RGD:1603666 6480464 Copper Sulfate results in decreased expression of HIGD1A mRNA CTD PMID:19549813 crocidolite asbestos increases expression ISO RGD:1603666 6480464 Asbestos, Crocidolite results in increased expression of HIGD1A mRNA CTD PMID:29523930 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of HIGD1A mRNA CTD PMID:19770486 cyclosporin A decreases expression ISO RGD:1603666 6480464 Cyclosporine results in decreased expression of HIGD1A mRNA CTD PMID:20106945 , PMID:25562108 dexamethasone increases expression ISO RGD:1603666 6480464 Dexamethasone results in increased expression of HIGD1A mRNA CTD PMID:25047013 dicrotophos decreases expression ISO RGD:1603666 6480464 dicrotophos results in decreased expression of HIGD1A mRNA CTD PMID:28302478 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of HIGD1A mRNA CTD PMID:20880076 diuron increases expression ISO RGD:620215 6480464 Diuron results in increased expression of HIGD1A mRNA CTD PMID:21551480 doxorubicin decreases expression ISO RGD:1603666 6480464 Doxorubicin results in decreased expression of HIGD1A mRNA CTD PMID:29803840 finasteride increases expression ISO RGD:620215 6480464 Finasteride results in increased expression of HIGD1A mRNA CTD PMID:24136188 fluoranthene multiple interactions EXP 6480464 [1-methylanthracene co-treated with fluoranthene] results in decreased expression of HIGD1A mRNA CTD PMID:28329830 flutamide increases expression ISO RGD:620215 6480464 Flutamide results in increased expression of HIGD1A mRNA CTD PMID:24136188 glafenine increases expression ISO RGD:620215 6480464 Glafenine results in increased expression of HIGD1A mRNA CTD PMID:24136188 haloperidol increases expression EXP 6480464 Haloperidol results in increased expression of HIGD1A mRNA CTD PMID:14647396 methapyrilene increases expression ISO RGD:620215 6480464 Methapyrilene results in increased expression of HIGD1A mRNA CTD PMID:30467583 methotrexate affects expression EXP 6480464 Methotrexate affects the expression of HIGD1A mRNA CTD PMID:18502557 methylmercury chloride decreases expression ISO RGD:1603666 6480464 methylmercuric chloride results in decreased expression of HIGD1A mRNA CTD PMID:28001369 mifepristone increases expression ISO RGD:1603666 6480464 Mifepristone results in increased expression of HIGD1A mRNA CTD PMID:17584828 nefazodone increases expression ISO RGD:620215 6480464 nefazodone results in increased expression of HIGD1A mRNA CTD PMID:24136188 nickel dichloride affects expression ISO RGD:620215 6480464 nickel chloride affects the expression of HIGD1A mRNA CTD PMID:22110744 nickel dichloride increases expression EXP 6480464 nickel chloride results in increased expression of HIGD1A mRNA CTD PMID:12839937 nimesulide increases expression ISO RGD:620215 6480464 nimesulide results in increased expression of HIGD1A mRNA CTD PMID:24136188 oxaliplatin multiple interactions ISO RGD:620215 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of HIGD1A mRNA CTD PMID:25729387 paracetamol affects expression EXP 6480464 Acetaminophen affects the expression of HIGD1A mRNA CTD PMID:17562736 perfluorooctanoic acid increases expression ISO RGD:620215 6480464 perfluorooctanoic acid results in increased expression of HIGD1A mRNA CTD PMID:19162173 phenylephrine increases expression ISO RGD:620215 6480464 Phenylephrine results in increased expression of HIGD1A mRNA CTD PMID:18158353 pirinixic acid increases expression ISO RGD:620215 6480464 pirinixic acid results in increased expression of HIGD1A mRNA CTD PMID:19162173 pirinixic acid multiple interactions ISO RGD:1603666 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of HIGD1A mRNA CTD PMID:19710929 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of HIGD1A mRNA CTD PMID:17426115 pregnenolone 16alpha-carbonitrile decreases expression ISO RGD:620215 6480464 Pregnenolone Carbonitrile results in decreased expression of HIGD1A mRNA CTD PMID:19162173 quercetin affects expression ISO RGD:620215 6480464 Quercetin affects the expression of HIGD1A mRNA CTD PMID:18178720 rac-lactic acid decreases expression ISO RGD:1603666 6480464 Lactic Acid results in decreased expression of HIGD1A mRNA CTD PMID:30851411 Soman decreases expression ISO RGD:620215 6480464 Soman results in decreased expression of HIGD1A mRNA CTD PMID:19281266 sulindac increases expression ISO RGD:620215 6480464 Sulindac results in increased expression of HIGD1A mRNA CTD PMID:24136188 tamoxifen affects expression EXP 6480464 Tamoxifen affects the expression of HIGD1A mRNA CTD PMID:17555576 Tesaglitazar increases expression ISO RGD:620215 6480464 tesaglitazar results in increased expression of HIGD1A mRNA CTD PMID:21515302 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of HIGD1A mRNA CTD PMID:17484886 tolcapone decreases expression ISO RGD:620215 6480464 tolcapone results in decreased expression of HIGD1A mRNA CTD PMID:24136188 topotecan multiple interactions ISO RGD:620215 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of HIGD1A mRNA CTD PMID:25729387 topotecan increases expression ISO RGD:620215 6480464 Topotecan results in increased expression of HIGD1A mRNA CTD PMID:25729387 triclosan decreases expression ISO RGD:1603666 6480464 Triclosan results in decreased expression of HIGD1A mRNA CTD PMID:30510588 tungsten increases expression EXP 6480464 Tungsten results in increased expression of HIGD1A mRNA CTD PMID:30912803 tungsten(4+) increases expression EXP 6480464 Tungsten results in increased expression of HIGD1A mRNA CTD PMID:30912803 valproic acid decreases methylation ISO RGD:1603666 6480464 Valproic Acid results in decreased methylation of HIGD1A gene CTD PMID:29154799 valproic acid affects expression ISO RGD:1603666 6480464 Valproic Acid affects the expression of HIGD1A mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:1603666 6480464 Valproic Acid results in increased expression of HIGD1A mRNA CTD PMID:23179753 more ... vorinostat increases expression ISO RGD:1603666 6480464 vorinostat results in increased expression of HIGD1A mRNA CTD PMID:27188386 
Gene Ontology Annotations
